Company
Headquarters: Melbourne, VIC, Australia
A$5.3 Million
AUD as of Jan. 1, 2024
US$3.6 Million
Company | Market Cap (USD) |
---|---|
Abbott | $192.67 B |
Stryker Corporation | $113.24 B |
Medtronic | $111.60 B |
Boston Scientific Corporation | $85.22 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
InhaleRx Limited focuses on developing inhalation therapies in Australia and internationally. It offers medical inhalation devices for the delivery of prescribed medicines. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled medicinal cannabinoid formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Sydney, Australia.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
InhaleRx Ltd has the following listings and related stock indices.
Stock: ASX: IRX wb_incandescent